Skip to main content
. 2022 May 27;40(30):4017–4025. doi: 10.1016/j.vaccine.2022.05.046

Fig. 1.

Fig. 1

Experimental Design Female BALB/c mice were intramuscularly vaccinated twice (Days 0 and 21) with 0.1 mL of control (PBS), CoVLP or CoVLP.B1351 adjuvanted with AS03 (final CoVLP dose of 3.75 µg) as homologous or heterologous prime-boost regimen. n, number of mice within the group. Syringe indicates immunization day. Red drop indicates blood collection day.